It is important to understand how cardiac hypertrophy develops, not only because it manifests as diastolic dysfunction and often leads to congestive heart failure but also because it is an independent risk factor for many cardiac diseases such as ischemic heart disease, arrhythmia and sudden death. 1
Mechanical Stress Induces Cardiac Hypertrophy
A growing body of evidence suggests that humoral factors in the circulating blood have a marginal effect on the development of cardiac hypertrophy in response to hemodynamic overload and that mechanical stress induces cardiac hypertrophy via an increase in the local production of humoral factors.
How is mechanical stress perceived by a cardiomyocyte as a stimulus? With the use of a Langendorf preparation, it has been shown that stretch of the ventricular wall as a Japanese Circulation Journal Vol. 65 , May 2001 consequence of increased aortic pressure is the mechanical parameter most closely related to an increase in protein synthesis. 2 This observation has been confirmed by experiments with cardiocytes cultured in vitro with serum-free media. When cardiocytes cultured on deformable silicone membranes were stretched, an increase in protein synthesis was observed, 3 and stretching the cardiocytes also induced expression of specific genes, such as immediate early response genes (IEG) and fetal type genes. [4] [5] [6] [7] These observations suggest that mechanical stress (hemodynamic overload) induces cardiac hypertrophy via stretching of the cardiomyocytes.
Neurohumoral Factors Mediate Mechanical Stress-Induced Cardiac Hypertrophy
The protein kinase cascade of phosphorylation is also activated by mechanical stress on cardiac myocytes and this event is very similar to that observed when growth factors and cytokines are added to many cell types. It was thus conceivable that cardiac myocytes and non-cardiomyocytes, such as fibroblasts, endothelial cells and smooth muscle cells, secrete some hypertrophy-promoting factors following stretch and that they induce cardiac hypertrophy by an autocrine or paracrine mechanism. 8 
Angiotensin II (Ang II)
A growing body of evidence indicates that the local renin -angiotensin system plays a critical role in the development of cardiac hypertrophy. 2 All components of the Japanese Circulation Journal Vol.65, May 2001 renin -angiotensin system, such as angiotensinogen, renin and angiotensin-converting enzyme (ACE), have been identified in the heart at both the mRNA and protein levels. Ang II stimulates protein synthesis in cultured cardiomyocytes, 2 and increases in angiotensinogen and ACE mRNAs have been reported in the hypertrophied left ventricle of rats. 9 Subdepressor doses of ACE inhibitors can prevent or cause regression of cardiac hypertrophy with no change in systemic systolic blood pressure. 10 An increase in left ventricular mass, which was produced by constriction of the abdominal aorta, without a significant increase in plasma renin activity, was completely prevented with an ACE inhibitor without any change in afterload. 11 These results strongly suggest that the local renin -angiotensin system, not the circulating one, plays a critical role in pressure overload-induced cardiac hypertrophy.
Ang II induces activation of protein kinases, including ERKs, and expression of IEG, such as c-fos and c-jun, as well as an increase in protein synthesis, in neonatal rat cardiocytes through the Ang II type 1 receptor (AT1). 12, 13 Activation of ERKs and up-regulation of c-fos expression by Ang II are blocked by protein kinase C (PKC) inhibitors, and Ang II actually increases production of inositol phosphates and activates PKC. 12, 13 These signals elicited by Ang II in cardiac myocytes are very similar to those evoked by mechanical stress, so the involvement of Ang II in the stretch-induced hypertrophic responses was examined using AT1-specific inhibitors. AT1 antagonists partially but significantly suppressed all stretch-induced hypertrophic responses, such as an increase in amino acid incorporation, the induction of c-fos expression and the activation of ERKs. 14, 15 Together with the discovery that Ang II is stored in secretory granules in neonatal ventricular myocytes and that mechanical stretch causes a release of Ang II from cultured cardiocytes, 14 although how it induces this release of Ang II from the secretory granules remains to be elucidated, the results suggest that Ang II is responsible at least in part for the hypertrophic responses evoked by mechanical stress on cardiac myocytes.
The intracellular signaling pathways evoked by Ang II are different among cell types. It markedly activated ERKs in cardiac myocytes and although Ang II activates Fyn, a Src family tyrosine kinase and Ras, 16 inhibition of these molecules has no effect on Ang II-induced ERK activation. Instead, only down-regulation of PKC, or a PKC inhibitor, calphostin C, abolished the Ang II-induced ERK activation. 17 Ang II also activated Raf-1 kinase and MEK, and the activation of these kinases is also suppressed by inhibition of PKC. Because PKC has been reported to directly activate Raf-1 kinase, Ang II possibly activates ERKs through PKC, Raf-1 and MEK. The signaling pathways from AT1 to ERKs are divergent among cell types. In smooth muscle cells, pertussis toxin has no effect, but phospholipase C (PLC), Ca 2+ and the Src family are critical for Ang IIinduced activation of ERKs. Ang II possibly activates ERKs through Gq-PLC -Ca 2+ -Ca 2+ -dependent tyrosine kinase Pyk2 and Src-Shc-Grb2-Sos-Ras-ERKs. 17 Cardiac fibroblasts produce and secret extracellular matrix proteins such as collagen and fibronectin in response to Ang II, which subsequently induces fibrosis of the heart. In cardiac fibroblasts, Ang II activates ERKs through pertussis toxin sensitive G protein, possibly Gi protein. The subunit of Gi activates Src and then ERKs through Shc-Grb2-SosRas. 18 It remains to be determined why the signaling pathways are so divergent among cell types.
Endothelin-1 (ET-1)
ET-1 is a potent inducer of cardiac hypertrophy. 19 Stretchinduced activation of ERKs is also suppressed by type A ET-1 (ETA) receptor antagonist, 20 suggesting that ET-1 is involved in mechanical stress-induced hypertrophic responses. Because ET-1-induced activation of ERKs is also inhibited by down-regulation of PKC, ET-1 possibly activates ERKs through the same pathway as Ang II. It was recently reported that Ang II does not have direct potent hypertrophy-promoting effects on cardiac myocytes, but that it evokes the hypertrophic responses in cardiac myocytes by inducing ET-1 secretion from cardiac fibroblasts. 21 Crosstalk among different cell types and among many molecules might be important not only for maintaining the highly differentiated phenotypes, but also for inducing cardiac hypertrophy. The beneficial effects of ET-1 receptor antagonists on myocardial infarction highlight the importance of ET-1 on cardiovascular remodeling. 22 The importance of Gq protein in the development of pressure overload-induced cardiac hypertrophy was recently demonstrated using transgenic mice. 23 Class-specific inhibition of Gq-mediated signaling was produced in the murine heart by targeted expression of a carboxyl-terminal peptide of the alpha subunit of Gq. When pressure overload was surgically produced, the transgenic mice developed significantly less ventricular hypertrophy than control mice. Although cardiac hypertrophy was not completely prevented in the transgenic mice, the study suggests that Gq-coupled receptors, such as AT1, ETA receptor and another 7 transmembrane receptors, are important in the development of pressure overload-induced cardiac hypertrophy.
Mechanisms by Which Mechanical Stress is Converted Into Biochemical Signals

Stretch-Sensitive Ion Channels
Many cells respond to a variety of environmental stimuli by ion channels in the plasma membrane. Mechanosensitive ion channels have been observed with single-channel recordings in more than 30 cell types of prokaryotes, plants, fungi and all animals so far examined. 24 The activation of stretch-sensitive channels has been proposed as the transduction mechanism between load and protein synthesis in cardiac hypertrophy 25 because these channels allow the passage of the major monovalent physiological cations, Na + and K + , and the divalent cation, Ca 2+ . Using a Ca 2+ -binding fluorescent dye (fluo3) and the patch clamp technique, mechanically induced Ca 2+ influx through the stretch channels was shown to lead to waves of calcium-induced calcium release. 26 Therefore, the stretch-sensitive ion channels are a good candidate for the initial responder to mechanical stress.
The importance of Ca 2+ in the development of cardiac hypertrophy was recently highlighted when it was reported that overexpression of constitutively active mutants of a Ca 2+ -dependent phosphatase calcineurin, and of its downstream transcription factor NFAT3, induced marked cardiac hypertrophy in transgenic mice, and that phenylephrineand Ang II-induced cardiomyocyte hypertrophy in vitro was inhibited by calcineurin inhibitors. 27 These observations suggest that an increase in intracellular Ca 2+ levels could induce cardiac hypertrophy by activating calcineurin. Shimoyama et al also investigated whether calcineurin is involved in load-induced cardiac hypertrophy and found that pressure overload-induced cardiac hypertrophy was significantly suppressed by calcineurin inhibitors such as cyclosporine A and FK506. 28, 29 Using an in-vitro stretch device, we found that when cultured cardiac myocytes were stretched by 20% for 30 min, the brain natriuretic peptide (BNP) gene was upregulated. The upregulation of BNP was suppressed by gadolinium (an inhibitor of stretch-sensitive ion channels) and attenuated by FK506. These results suggest that Ca 2+ , which enters cardiomyocytes through the stretch-sensitive ion channels, plays a critical role in stretchinduced gene expression.
Extracellular Matrix and Cytoskeleton
Many studies have suggested that the mechanical stress is transduced into the cell from the sites at which cells attach to the extracellular matrix (ECM). 30 Therefore, transmembrane ECM receptors, such as the integrin family, are also good candidates for mechanoreceptors. A large extracellular domain of the integrin receptor complex binds various ECM proteins, and a short cytoplasmic domain has been shown to interact with the cytoskeleton proteins in the cell. 31 Because cytoskeleton proteins can potentially regulate plasma membrane proteins, such as enzymes, ion channels and antiporters, mechanical stress could modulate these membrane-associated proteins and stimulate second messenger systems through the cytoskeleton. Integrins can transmit signals not only by organizing the cytoskeleton but also by altering its biochemical properties, such as the extent of tyrosine phosphorylation of a complex of proteins including pp125 fak . 30 Stretching cultured mesangial cells actually enhanced phosphorylation of pp125 fak . 32 Recently obtained results also indicate that integrin plays a critical role in stretch-induced hypertrophic signals (Komuro, unpublished data). When the outside-in signal of integrin was inhibited, stretch-induced activation of p38MAPK was strongly suppressed. Stretching induced tyrosine phosphorylation of both FAK and Src. Stretch-induced activation of p38MAPK was abolished by overexpression of FAT and CSK, which are inhibitors of FAK and the Src family, respectively. These results suggest that mechanical stress activates p38MAPK through the integrin -FAK -Src pathway in cardiac myocytes.
The Rho small G protein family consisting of Rho, Rac and Cdc42 is important for the function of integrins through regulating the actin cytoskeleton. 33 When functions of the Rho family are inhibited by C3 exoenzyme or by overexpression of Rho GDP dissociation inhibitor and dominant negative mutants, stretch-induced activation of ERKs and expression of IEG are greatly suppressed. 34 The C3 exoenzyme inhibits MEKK-and PHE-induced atrial natriuretic peptide (ANP) expression, but not actin organization, indicating that Rho regulates ANP expression but not sarcomere assembly. 35 Sah et al also reported that Rho is involved in PHE-and Gaq-induced, but not in Ras-induced, ANP expression. 36 Activated RhoA and Ras have a synergistic effect on ANP expression, suggesting that Rho functions in a pathway separate from but complementary to Ras. Treatment of myocytes with Ang II caused formation of nonstriated actin fiber (premyofibrils), which was abolished by the C3 treatment, 37 and expression of constitutively active RhoA also caused the formation of premyofibrils, which suggests that RhoA is only involved in premyofibril formation.
Future Directions
Once mechanical stress is received and converted into biochemical signals, the signal transduction pathway leading to an increase in protein synthesis is similar to the pathway that is activated by various humoral factors, such as growth factors, hormones and cytokines, in many other cells. Yeast genes encoding members of MAP kinase have been isolated, by complementation of yeast mutations, as an essential protein for restoring the osmotic gradient across the cell membrane in response to increased external osmolality, 38 which suggests that mechanical stress-induced intracellular signal transduction pathways are highly conserved in evolution.
Although many of the biochemical events that occur in cardiac myocytes subsequent to mechanical stretch have been clarified, the main intriguing question remains unanswered: How is mechanical stress converted into biochemical signals? In other words, what is the mechanoreceptor or the transducer for mechanical stress in cardiac myocytes? It is conceivable that by stretching the plasma membrane, mechanical stress directly changes the conformation of the functional proteins in the membrane, such as the ion channels, receptors and G-proteins, or directly activates enzymes, such as phospholipases, by physically placing the enzymes close to their phospholipid substances in the plasma membrane. As mentioned earlier, the integrin -cytoskeleton complex is a likely alternate candidate structure for a mechanoreceptor and a transducer. Integrin-cytoskeleton proteins not only play a 'passive' role in maintaining the cell structure, but may also have an 'active' role in the regulation of cellular functions such as protein phosphorylation and activation of an antiporter. The cytoskeleton has been also shown to play an important role in secretion and mechanical stress may stimulate secretion of some cytokines, which generate multiple intracellular signals as a secondary event. Further studies are necessary to identify specific signaling molecules, including mechanoreceptors and mechanotransducers, and characterization of these molecules may pave the way to understanding the definite mechanism of mechanical stress-induced cardiac hypertrophy and to finally clarify the mechanisms by which adaptive cardiac hypertrophy deteriorates into congestive heart failure.
II. Molecular Mechanism of Cardiac Development
Murine Csx/Nkx-2.5 is a homeobox-containing gene originally identified as a potential vertebrate homolog of the Drosophila gene tinman. 39, 40 The loss-of-function mutant of tinman manifests as complete loss of heart formation, indicating that the gene is essential for Drosophila heart formation. 41, 42 The expression of Csx/Nkx-2.5 is also highly restricted to the heart and the heart progenitor cells from the very early developmental stage when the 2 heart primordia are symmetrically situated in the anterior lateral mesoderm, 39, 40 and targeted disruption of the murine Csx/Nkx-2.5 results in embryonic lethality because of the abnormal looping morphogenesis of the primary heart tube. 43 Furthermore, the Csx/Nkx-2.5-family genes have been identified in various vertebrate species from zebra fish to humans. [44] [45] [46] [47] These results indicate that Csx/Nkx-2.5 is also essential for normal heart development and morphogenesis in vertebrates, similar to the role of tinman in Drosophila, and suggest that the regulatory mechanism of heart development controlled by Csx/Nkx-2.5 is highly Japanese Circulation Journal Vol.65, May 2001 conserved in evolution. In order to clarify the molecular framework of vertebrate cardiogenesis, the identification of upstream regulatory factors that control the expression of Csx/Nkx-2.5 and the downstream targets of Csx/Nkx-2.5 protein is necessary. [48] [49] [50] 
Downstream Target Genes of Csx Protein
To search for the direct downstream target genes of Csx/Nkx-2.5, 51 Shiojima et al co-transfected luciferase reporter constructs containing various cardiac-specific gene promoters and the Csx/Nkx-2.5 expression vector into COS-7 cells, and examined whether the transcription of native promoters was activated by overexpression of Csx/Nkx-2.5. Among the reporter constructs tested, Csx/Nkx-2.5 most strongly transactivated the ANP-luciferase reporter containing the 600-bp 5' flanking region of the rat ANP gene, suggesting that ANP is a downstream target. Although deletion of the ANP 5' flanking region from -600 to -390 did not significantly change the fold activation of the ANP promoter by Csx/Nkx-2.5, the deletion between -390 and -160 markedly reduced the fold induction of the promoter activity, indicating that the Csx/Nkx-2.5-responsive element is situated between -390 and -160 of the ANP 5' flanking region. The consensus Csx/Nkx-2.5-binding element (TGAAGTG) was located at -250 of the ANP promoter. The deletion or the mutation of the Csx/Nkx-2.5-binding element located at -250 of the ANP promoter markedly reduced the fold induction of transactivation by Csx/Nkx-2.5.
Csx/Nkx-2.5 and GATA-4 Interact and Synergistically Transactivate ANP Promoter
Because the GATA site is located at -280, just distal from the Csx/Nkx-2.5 binding site, it was investigated whether Csx/Nkx-2.5 and GATA-4 cooperatively regulate the transcription of ANP. When the ANP(300)-luc construct containing the 300-bp 5' flanking region of the ANP promoter was co-transfected with Csx/Nkx-2.5 expression plasmid alone, modest transactivation of the ANP promoter was observed. When ANP(300)-luc was co-transfected with GATA-4 expression plasmid alone, no significant increase in the promoter activity was observed, suggesting that GATA-4 is a weak transactivator of ANP promoter under these assay conditions. However, overexpression of both GATA-4 and Csx/Nkx-2.5 induced much stronger activity of the ANP promoter than that induced by the expression of Csx/Nkx-2.5 alone, suggesting that Csx/Nkx-2.5 and GATA-4 synergistically transactivate the ANP promoter.
Removal of the region between -300 and -270 of the ANP promoter, which resulted in the deletion of the GATA site at -280, had little effect on the Csx/Nkx-2.5-GATA-4 synergism or on Csx/Nkx-2.5-induced activation. However, deletion of the promoter region between -270 and -240, in which the Csx/Nkx-2.5 binding site is located, abolished not only Csx/Nkx-2.5-induced activation of the ANP promoter, but also the cooperative action between Csx/Nkx-2.5 and GATA-4, suggesting that the Csx/Nkx-2.5 binding site, but not the GATA site at -280, is required for the Csx/Nkx-2.5-GATA-4 transcriptional synergism. Co-immunoprecipitation experiments revealed that Csx/Nkx-2.5 and GATA-4 interact in vivo. GST pull-down assay showed that the homeodomain of Csx/Nkx-2.5 and the zinc finger domain of GATA-4 are important for their association.
In Drosophila, the homeobox-containing gene tinman is expressed in the developing dorsal vessel, and its expression is regulated by decapentaplegic (dpp), a member of the transforming factor-(TGF-) superfamily. 52 
BMP, a Member of the TGFSuperfamily, Plays a Critical Role in Cardiomyocyte Differentiation
To determine whether BMP, a mammalian dpp homolog, is necessary for cardiomyocyte differentiation, Monzen et al 53 used a clonal derivative named P19CL6, which efficiently differentiates into beating cardiac muscle in adherent culture with 1% DMSO. In order to confirm that BMP signaling pathways are involved in cardiomyocyte differentiation in P19CL6 cells, expression vectors carrying mutants of TAK1, which is a member of the MAPKKK family and is thought to be one of the mediating molecules that transduct BMP signaling, 54 were transfected into P19CL6noggin cells. Two days after the initiation of the DMSO treatment (day 2), expression plasmids containing wild-type mouse TAK1 cDNA (TAK1WT), a constitutively active form of TAK1 (TAK1∆N), and the dominant negative form of TAK1 (TAK1KN) were transiently transfected by the lipofection method. The cells were designated P19CL6noggin + TAK1WT, + TAK1∆N and + TAK1KN, respectively. The culture was maintained continuously in differentiation medium, until immunofluorescence study or RNA extraction was performed on day 14. Unlike the control P19CL6noggin cells, P19CL6noggin + TAK1WT and + TAK1∆N cells partially differentiated into mononucleate, spontaneously beating cardiomyocytes, suggesting that overexpression of TAK1 can rescue the differentiation defect of P19CL6noggin.
To make further elucidate how BMP signaling is involved in the induction of cardiac-specific transcription factors, expression vectors containing Csx/Nkx-2.5 and GATA-4 were transfected into P19CL6noggin cells and their cardiogenic activity was examined. Expression plasmids containing human CSX1a cDNA or mouse GATA-4 cDNA were transfected into P19CL6noggin cells, designated P19CL6 noggin + CSX, + GATA-4 and + CSX + GATA-4, respectively. Interestingly, although P19CL6noggin + CSX and P19CL6noggin + GATA-4 did not differentiate into beating cardiomyocytes, P19CL6noggin + CSX + GATA-4 did partly differentiate into rhythmically contracting cardiomyocytes. These results suggest that Csx/Nkx-2.5 and GATA-4 together are required for cardiomyocyte differentiation in P19CL6noggin cells and that both of them are regulated by BMP.
Speculation on the Regulatory Network Controlling Heart Development
In the avian embryo, recent excellent work by Shultheiss et al has revealed that BMP-2 and BMP-4 administration can induce full cardiac differentiation in the anterior medial mesoderm, a tissue that is not normally cardiogenic, but not in the posterior mesoderm, and also demonstrated that administering noggin to explanted precardiac mesoendoderm inhibits cardiac differentiation of this tissue. 55 Taken together, it is considered that BMP is necessary for avian cardiogenesis, but is not sufficient on its own and that the anterior endoderm is likely to produce a factor that interacts with BMP to induce cardiogenesis specifically in the anterior mesoderm. 55 My current study using P19CL6, a newly-established useful in-vitro model, has demonstrated for the first time that BMP is indispensable for the induction of cardiomyocyte differentiation in a murine cell line (unpublished data). On the other hand, when cultured continuously without DMSO treatment, even parental P19CL6 cells do not differentiate into cardiomyocytes (unpublished data). This finding corroborates that BMP function alone is not sufficient for cardiogenesis and that the other crucial factors for cardiomyocyte differentiation in this cell line are probably induced by the DMSO treatment. The precise role of DMSO in the differentiation of P19 cells is currently unknown, but when administered at appropriate concentration, DMSO transactivates some unknown factors that are involved in the cardiac specification in this cell line, and both BMP and the unknown factors seem to cooperatively function to determine the cardiogenic cell fates. In P19 cells, untreated aggregates contain a few extra-embryonic endodermal cells as well as undifferentiated embryonal carcinoma cells, and the similar endoderm-like cells are also observed in P19CL6 cells (unpublished data). It is possible that the factors produced by these endoderm cells after the DMSO treatment act on other undifferentiated cells to become cardiac muscle just as in the model of avian cardiogenesis, in which signals from the anterior endoderm interact with BMP to induce cardiogenesis specifically in the anterior mesoderm. 55 Identification of the unknown factors induced by the DMSO treatment in this P19 cell derivative would be a great breakthrough for the elucidation of the mechanisms of cardiac development.
